MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Corticobasal degeneration (CBD)"

  • 2018 International Congress

    Corticobasal Syndrome: A Single Center Case Series

    M. Siddiqui, C. Goas (Winston Salem, NC, USA)

    Objective: To evaluate clinical features of corticobasal syndrome in a tertiary care setting. Background: None. Methods: A retrospective chart review was done. All patients diagnosed…
  • 2018 International Congress

    Background pathology of ‘corticobasal degeneration (CBD) mimics’ -Japanese validation study of CBD (J-VAC study)

    T. Shimohata, I. Aiba, M. Yoshida, Y. Toyoshima, S. Murayama, T. Uchihara, T. Arai, Y. Saito, H. Takigawa, K. Hasegawa, T. Ikeuchi, M. Hasegawa, T. Komori, K. Wakabarashi, A. Tokumaru, K. Sakurai, K. J-VAC study (Gifu, Japan)

    Objective: To determine the background pathology of Japanese patients with ‘corticobasal degeneration (CBD) mimics’. Background: Recent research has focused on the development of disease-modifying treatments…
  • 2017 International Congress

    Progressive supranuclear palsy presenting with corticobasal syndrome: a case report

    M. Sousa, R. Varela, C. Januário, A. Morgadinho (Coimbra, Portugal)

    Objective: Clinical description and interpretation of complementary diagnostic exams of a patient with probable PSP with corticobasal syndrome phenotype (PSP-CBS). Background: Underlying pathologies of CBS…
  • 2017 International Congress

    Corticobasal degeneration and frontotemporal dementia – an overlapping continuum

    R. Varela, C. Duque, J. Carvalho, A. Moreira, A. Morgadinho, C. Januário (Coimbra, Portugal)

    Objective: This clinical case intends to highlight the continuum between frontotemporal dementia and corticobasal syndrome. Background: A substantive overlap between corticobasal degeneration and frontotemporal dementia…
  • 2017 International Congress

    In vivo evaluation of tau and amyloid pathology in Corticobasal Syndrome

    F. Niccolini, H. Wilson, S. Hirschbichler, G. Pagano, R. Erro, T. Yousaf, A. Whittington, J. Holton, D. Martino, E. Rabiner, R. Gunn, K. Bhatia, M. Politis (London, United Kingdom)

    Objective: To assess in vivo, with molecular imaging the brain distribution of tau aggregates ([18F]AV1451 PET) and β-amyloid depositions ([18F]AV45 PET) in patients with Corticobasal…
  • 2017 International Congress

    Dextrometorphan/quinidine in Atypical Parkinsonisms and Huntington Disease

    J. Etcheverry, M. Cesarini, G. Rojas, E. Gatto (Buenos Aires, Argentina)

    Objective: to determine whether Dextrometorphan/quinidine (DMQ) is effective in the treatment of PBA, AG or bulbar symptoms in corticobasal syndrome (CBS), multiple system atrophy (MSA),…
  • 2017 International Congress

    Blink reflex recovery cycle to differentiate Progressive Supranuclear Palsy from Corticobasal Degeneration

    G. Sciacca, A. Nicoletti, G. Mostile, A. Luca, L. Raciti, V. Dibilio, F. Le Pira, M. Zappia (Catania, Italy)

    Objective: To evaluate R2 Blink Reflex Recovery Cycle (BRRC) in patients with Progressive Supranuclear Palsy (PSP) and CorticoBasal Degeneration (CBD) and to determine its diagnostic…
  • 2017 International Congress

    Corticobasal syndrome due to brain tumor

    P. Tsitsi, G. Xiromerisiou, T. Kalantzakou, T. Bourinaris, G. Deretzi (Stockholm, Sweden)

    Objective: To describe a case of a 60-year-old female that presented with cognitive decline and gait disorders for the last 7 years.   Background: The…
  • 2017 International Congress

    The Corticobasal Degeneration Functional Rating Scale (CBD-FS)

    A. Lang, G. Stebbins, A. Boxer (Toronto, Canada)

    Objective: To develop a patient/care giver-reported scale that is capable of assessing functional disability in CBD that can be easily and reliably used in clinical…
  • 2017 International Congress

    Signal intensity of cerebral gyri in corticobasal degeneration on phase difference enhanced MR images: Comparison with progressive supranuclear palsy and Parkinson’s disease

    M. Miyata, S. Kakeda, T. Yoneda, S. Ide, K. Watanabe, J. Moriya, H. Narimatsu, T. Sato, K. Okada, H. Adachi, Y. Korogi (Kitakyushu, Japan)

    Objective: We evaluated the signal intensity of the cerebral gyri (CG) on phase difference enhanced imaging (PADRE) for the patients with corticobasal degeneration (CBD), progressive…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley